SCHEMBL6019846

SCHEMBL6019846

CCN(C#N)C(=O)C(Cc1csc2ccccc12)NC(=O)Nc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 1/20 0.47
CTSL P07711 1/20 0.46
CTSS P25774 1/20 0.46
CTSK P43235 1/20 0.46
TACR1 P25103 1/20 0.42
MAPT P10636 3/20 0.41
LMNA P02545 1/20 0.41
PTBP1 P26599 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
EPHX2 P34913 1/20 0.38
GOT1 P17174 1/20 0.38
MCHR1 Q99705 1/20 0.38
STING1 Q86WV6 1/20 0.37
IGF1R P08069 2/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP8 P22894 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019269 0.92 CTSL (0.44) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6019585 0.89 TACR1 (0.48) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6020979 0.89 CTSL (0.47) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6020086 0.89 CTSL (0.44) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6021175 0.87 CTSL (0.48) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6020714 0.87 CTSL (0.44) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6019780 0.87 CTSL (0.45) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6020846 0.84 CTSS (0.63) FPR2CTSLCTSSCTSKTACR1
SCHEMBL6021811 0.84 LMNA (0.56) FPR2CTSLCTSSCTSKMAPT
SCHEMBL6020962 0.84 CTSL (0.44) CTSLCTSSCTSKTACR1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US claimed
EP-1575903-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES Jerini AG (DE) 2005-09-21 EP claimed
WO-2004065353-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES JERINI AG (DE) 2004-08-05 WO claimed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO claimed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP claimed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP claimed
US-20060252813-A1 Apparatus for curing a composite laminate JERINI AG (DE) 2006-11-09 US disclosed
WO-2004056755-A2 COMPOUNDS FOR THE INHIBITION OF NON-PROTEOLYTIC ENZYMES JERENI AG (DE) 2004-07-08 WO disclosed
EP-1433778-A1 Use of nitriles as rotamase inhibitors Jerini AG (DE) 2004-06-30 EP disclosed
EP-1433779-A1 Use of nitriles as inhibitors of non-proteolytic enzymes Jerini AG (DE) 2004-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252813-A1 Apparatus for curing a composite laminate DHX29, HDHD5, DHRS9 FPR2 3247/4885CTSL 2274/4885CTSS 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.